Thomas Catinazzo
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $5.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,511105,340 held (−14%) | $18.58 | $325K | -3.8% |
| Oct 8SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 206105,134 held (−0%) | $19.26 | $4K | -7.2% |
| Sep 9SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717122,851 held (−13%) | $18.94 | $336K | -5.6% |
| Aug 18SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717140,568 held (−11%) | $19.74 | $350K | -9.4% |
| Jul 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 1,459158,285 held (−1%) | $18.61 | $27K | -3.9% |
| Jul 8SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717159,744 held (−10%) | $18.69 | $331K | -4.3% |
| Jun 24SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717177,461 held (−9%) | $17.01 | $301K | +5.1% |
| Jun 24SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 56,323177,461 held (−24%) | $16.97 | $956K | +5.4% |
| Jun 24SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 61,563177,461 held (−26%) | $16.97 | $1.0M | +5.4% |
| Jun 24SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 51,560177,461 held (−23%) | $16.97 | $875K | +5.4% |
| May 14SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717195,178 held (−8%) | $12.86 | $228K | +39.0% |
| Apr 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 972212,895 held (−0%) | $14.79 | $14K | +20.9% |
| Apr 9SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717213,867 held (−8%) | $13.01 | $230K | +37.4% |
| Apr 9SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 1,800213,867 held (−1%) | $15.00 | $27K | +19.2% |
| Mar 11SEC | RLAYRelay Therapeutics, Inc. | Sell Plan | 17,717231,584 held (−7%) | $10.06 | $178K | +77.7% |
| Jan 29SEC | RLAYRelay Therapeutics, Inc. | Sell | 13,820250,996 held (−5%) | $7.62 | $105K | +134.6% |
| Jan 29SEC | RLAYRelay Therapeutics, Inc. | Sell | 1,695249,301 held (−1%) | $8.45 | $14K | +111.6% |
| Oct 30SEC | RLAYRelay Therapeutics, Inc. | Sell | 21,664313,631 held (−6%) | $7.29 | $158K | +145.3% |
- Sell
CFO Thomas Catinazzo sold $325K of RLAY at $18.58 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Thomas Catinazzo sold $4K of RLAY at $19.26 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Thomas Catinazzo sold $336K of RLAY at $18.94 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Thomas Catinazzo sold $350K of RLAY at $19.74 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Thomas Catinazzo sold $331K of RLAY at $18.69 — pre-scheduled 10b5-1 plan sale.
- Sell
CFO Thomas Catinazzo sold $301K of RLAY at $17.01 — pre-scheduled 10b5-1 plan sale.